| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA678990 | F | In Vitro evaluation for the ratio of 50% minimum inhibitory concentration to 90% minimum inhibitory concentration against enterococci (19) | Enterococcus | 1 | organism-based format | Scientific Literature | ||
| 2. | ALA679161 | F | In Vitro evaluation for the ratio of 50% minimum inhibitory concentration to 90% minimum inhibitory concentration against enterococci EryRc (13) | Enterococcus | 1 | organism-based format | Scientific Literature | ||
| 3. | ALA683029 | F | In vitro inhibitory activity against Escherichia coli (250 UC5) | Escherichia coli | 53 | organism-based format | Scientific Literature | ||
| 4. | ALA695049 | F | In Vitro evaluation for the ratio of 50% minimum inhibitory concentration to 90% minimum inhibitory concentration against Haemophilus AmpR (37) | Haemophilus | 1 | organism-based format | Scientific Literature | ||
| 5. | ALA695050 | F | In Vitro evaluation for the ratio of 50% minimum inhibitory concentration to 90% minimum inhibitory concentration against Haemophilus AmpS (43) | Haemophilus | 1 | organism-based format | Scientific Literature | ||
| 6. | ALA690184 | F | In vitro inhibitory activity against Haemophilus influenzae (351CB12) | Haemophilus influenzae | 53 | organism-based format | Scientific Literature | ||
| 7. | ALA690185 | F | In vitro inhibitory activity against Haemophilus influenzae (351HT3) | Haemophilus influenzae | 53 | organism-based format | Scientific Literature | ||
| 8. | ALA690186 | F | In vitro inhibitory activity against Streptococcus pyogenes (02A1UC1) | Haemophilus influenzae | 1 | organism-based format | Scientific Literature | ||
| 9. | ALA717125 | F | In Vivo evaluation for its effective dose against Haemophilus influenzae (351RD7 AmpR beta (+)) | Mus musculus | 4 | organism-based format | Scientific Literature | ||
| 10. | ALA717126 | F | In Vivo evaluation for its effective dose against Haemophilus influenzae (351GR1) | Mus musculus | 4 | organism-based format | Scientific Literature | ||
| 11. | ALA717127 | F | In Vivo evaluation for its effective dose against Haemophilus influenzae (351TO19 AmpR beta (-)) | Mus musculus | 4 | organism-based format | Scientific Literature | ||
| 12. | ALA717128 | F | In Vivo evaluation for its effective dose against Staphylococcus aureus (011GO25 EryRi. | Mus musculus | 4 | organism-based format | Scientific Literature | ||
| 13. | ALA717730 | F | In Vivo evaluation for its effective dose against Staphylococcus aureus (011UC4). | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 14. | ALA719707 | F | In Vivo evaluation for its effective dose against Streptococcus pneumoniae (030Cr29 EryRc) | Mus musculus | 4 | organism-based format | Scientific Literature | ||
| 15. | ALA719708 | F | In Vivo evaluation for its effective dose against Streptococcus pneumoniae (030MV2 EryRc) | Mus musculus | 4 | organism-based format | Scientific Literature | ||
| 16. | ALA719709 | F | In Vivo evaluation for its effective dose against Streptococcus pneumoniae (030RO1 EryRi) | Mus musculus | 4 | organism-based format | Scientific Literature | ||
| 17. | ALA719710 | F | In Vivo evaluation for its effective dose against Streptococcus pneumoniae (030SJ1 EryRc) | Mus musculus | 4 | organism-based format | Scientific Literature | ||
| 18. | ALA719711 | F | In Vivo evaluation for its effective dose against Streptococcus pneumoniae (030SJ6 EryRc) | Mus musculus | 4 | organism-based format | Scientific Literature | ||
| 19. | ALA719712 | F | In Vivo evaluation for its effective dose against Streptococcus pneumoniae (032UC1) | Mus musculus | 3 | organism-based format | Scientific Literature | ||
| 20. | ALA719857 | F | In Vivo evaluation for its effective dose against Streptococcus pyogenes (02A1UC1) | Mus musculus | 3 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!